| Name | Title | Contact Details |
|---|
Were leading a fundamental rethinking of how diabetic limb complications are detected and monitored: noninvasive, mobile & point-of-care. Techstars backed!
Kootenai Health provides a comprehensive range of medical services to patients in north Idaho, eastern Washington, Montana and the Inland Northwest at several facility locations. The main campus at Kootenai Health is located in Coeur d`Alene, Idaho and includes a 299-bed community-owned hospital. By providing outstanding health care, Kootenai Health repeatedly earns regional and national recognition.
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.
Sponsored by the Franciscan Sisters of Mary and based in St. Louis, Mo., SSM Health Care (SSMHC) is one of the largest Catholic systems in the country.
GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases.